The Lancet: Correspondence: Obligations in a global health emergency
In this Correspondence letter to The Lancet, authors from MSF’s Access Campaign respond to a Viewpoint article, and challenge the status quo of patents and other intellectual property (IP) barriers that impede access to COVID-19 vaccines, treatments, tests and other health tools.
